drug development

Dimension raises $500M second fund for investing at the intersection tech and life sciences

Many VCs, particularly newer firms, readily admit that 2024 has been a challenging year for raising fresh capital. Dimension Capital, a two-year-old venture outfit, had a different experience when raising its second fund.   “Every investor from fund one came back very quickly,” said Zavian Dar (pictured center), one of the firm’s three founders and managing […]

Dimension raises $500M second fund for investing at the intersection tech and life sciences Read More »

Archon emerges from stealth with $20M and ‘antibody cages’ to power up drug development

Archon Biosciences, a biotech startup putting AI to work designing novel biomolecules, has just emerged from stealth with an impressive $20 million in seed funding. The company aims to supercharge antibody treatments using specially designed protein “cages” that multiply their effects, opening up new opportunities in drug development. This is the first company to be

Archon emerges from stealth with $20M and ‘antibody cages’ to power up drug development Read More »